Sudhoff Holger, Scholtz Lars Uwe, Gehl Hans Björn, Todt Ingo
Department of Otolaryngology, Head and Neck Surgery, Medical School OWL, Bielefeld University, Klinikum Bielefeld Mitte, Teutoburger Str. 50, 33604 Bielefeld, Germany.
Department of Radiology, Medical School OWL, Bielefeld University, Klinikum Bielefeld Mitte, 33604 Bielefeld, Germany.
Brain Sci. 2021 Sep 16;11(9):1221. doi: 10.3390/brainsci11091221.
The combination of intralabyrinthine schwannoma (ILS) removal and cochlear implantation is the standard of care after surgical resection for audiological rehabilitation. Intracochlear ILS is not only the most frequent tumor in this group of schwannomas, but it is also, to some degree, surgically the most challenging because of its position behind the modiolus. Recent developments in the knowledge of implant position, implant magnet choice, and magnetic resonance imaging (MRI) sequences make an MRI follow-up after surgical removal possible. Thus far, no results are known about the surgical success and residual rate of these kind of tumors. The aim of the present study was to perform an early MRI follow-up for the evaluation of residual or recurrent intracochlear ILS after surgical removal and cochlear implantation.
In a retrospective study, we evaluated seven patients after an intracochlear ILS removal and single-stage cochlear implantation with a mean period of 13.4 months post surgery with a 3T T1 GAD 2 mm sequence for a residual ILS. Patients were operated on using an individualized technique concept.
In six out of seven cases, 3 T T1 GAD 2 mm MRI follow-up showed no residual or recurrent tumor. In one case, a T1 signal indicated a tumor of the upper inner auditory canal (IAC) at the MRI follow up.
MRI follow-up as a quality control tool after ILS removal and cochlear implantation is highly important to exclude residual tumors. Long-term MRI evaluation results are needed and can be obtained under consideration of implant position, implant magnet, and MRI sequence choice. A preoperative MRI slice thickness less than 2 mm can be recommended to visualize possible modiolar and IAC expansion.
迷路内神经鞘瘤(ILS)切除与人工耳蜗植入相结合是手术切除后听力康复的标准治疗方法。耳蜗内ILS不仅是这类神经鞘瘤中最常见的肿瘤,而且由于其位于蜗轴后方,在某种程度上也是手术中最具挑战性的。植入位置、植入磁体选择和磁共振成像(MRI)序列知识的最新进展使得手术切除后进行MRI随访成为可能。迄今为止,尚无关于这类肿瘤手术成功率和残留率的结果。本研究的目的是在手术切除和人工耳蜗植入后进行早期MRI随访,以评估残留或复发性耳蜗内ILS。
在一项回顾性研究中,我们评估了7例耳蜗内ILS切除和单阶段人工耳蜗植入术后的患者,术后平均随访13.4个月,使用3T T1增强2mm序列检查残留ILS。患者采用个体化技术理念进行手术。
7例中有6例,3T T1增强2mm MRI随访显示无残留或复发肿瘤。1例在MRI随访中T1信号提示上内耳道(IAC)肿瘤形成。
MRI随访作为ILS切除和人工耳蜗植入后的质量控制工具,对于排除残留肿瘤非常重要。需要长期的MRI评估结果,可以在考虑植入位置、植入磁体和MRI序列选择的情况下获得。建议术前MRI切片厚度小于2mm,以观察蜗轴和IAC可能发生的扩张。